Skip to content

Ayurveda Treatment for Management of Hyperpigmentation (Melasma)

A Comparative Pharmaceutical- Analytical Study and Clinical Evaluation of Haridradi Lepa and Haridradi Cream in Vyanga Vis-A-Vis Melasma - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088417
Enrollment
40
Registered
2025-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

None listed

Sponsors

Dr Chandrika G
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting clinical features of Vyanga- painless, circular, thin, blackish patches on face. Chronicity less than 5 years.

Exclusion criteria

Exclusion criteria: Patients with known case of Carcinoma, Burns, Eczema, Psoriasis, Chickenpox, Leukoderma. Any history of allergy or hypersensitivity to creams or lotions.

Design outcomes

Primary

MeasureTime frame
Change in severity of pigmentation measured as per the assessment criteria- size, color, number of patches, mMASI score at baseline and after treatment.Timepoint: 0th day, 15th day, 30th day.

Secondary

MeasureTime frame
Adverse Events-Monitoring and documenting any side effects or complications arising from treatmentTimepoint: 1 months

Countries

India

Contacts

Public ContactDr Seethadevi P

JSS Ayurveda Medical College and Hospital

drsitadevi@gmail.com8431444499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026